Continuing therapeutic progress in lung cancer

At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 13–16 April 2016, Niki Karachaliou, MD, from the Dr Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain, highlights the development of targeted cancer therapeutic agents in combination as an important approach for the treatment of patients with lung cancer.

Share this video